An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
The severity of disease following infection with SARS-CoV-2 is determined by viral replication kinetics and host immunity, with early T cell responses and/or suppression of viraemia driving a favourable outcome. Recent studies uncovered a role for cholesterol metabolism in the SARS-CoV-2 life cycle...
| Auteurs principaux: | , , , , , , , , , , , , , , , , , |
|---|---|
| Autres auteurs: | |
| Format: | Journal article |
| Langue: | English |
| Publié: |
Public Library of Science
2023
|